Pharyngitis:治療薬市場動向2014(市場規模、グローバルAPIメーカー、第Ⅲ相試験)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIIR2014142)
◆英語タイトル: Pharyngitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DIIR2014142
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:75以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD2,000 ⇒換算¥222,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD4,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD6,000 ⇒換算¥666,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Pharyngitis:治療薬市場動向2014(市場規模、グローバルAPIメーカー、第Ⅲ相試験)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s, “ Pharyngitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. The report is also giving insight about the patent and exclusivity details of all the drugs across the indication.

Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


• A snapshot of the global Market therapeutics scenario for Pharyngitis.
• A review of the marketed products under prescription for Pharyngitis, regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for Pharyngitis with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
• Coverage of API Manufacturers for Pharyngitis drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Pharyngitis drugs.
• Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Pharyngitis drugs.
• Coverage of Pharyngitis Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
• Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
• Key discontinued Marketed products.
• Global Sales Figure from 2011-2015.

• Evaluate the marketing status and exclusivity details of Pharyngitis key products to exploit opportunities for generic drug development opportunities.
• Identify and understand important and diverse types of therapeutics under Phase III development for Pharyngitis.
• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to ‘Disease’.
• API intelligence over marketed drugs for Pharyngitis and gaining primary intelligence over active ingredients manufacturers across the globe.
• API intelligence over leading Phase III pipeline drugs.
• Develop and designstrategies by identifying the API manufacturers for Phase III pipeline products to enhance and expand business potential and scope.
• Understanding the scope of the Phase III Drugs with nil regulatory filings.
• Understanding the chemical route of synthesis of approved drugs for Pharyngitis.
• Uncovering opportunities in the rapidly growing the US markets.

*** レポート目次(コンテンツ)***

• Indication Overview
• Marketed Drugs Assessment
• Marketed Details of Drugs by Application Type
• Marketed Details of Drugs (NDA) by Marketing Status
• Marketed Details of Drugs by Patent Expiration Timeline
• The Active Pharmaceutical Ingredient (API) Manufacturers Assessment
• The API Manufacturers by the United States Drug Master File (US DMF) Status
• The API Manufacturers by the US DMF Status (Drug Specific)
• The Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
• The API Manufacturers by the US DMF Status (Drug Specific)
• Drugs Market Data and Forecasted Sales Figures (2011-2015)
• Marketed Drugs Information
• Drugs Description
• Route of Synthesis
• Global Active Pharmaceutical Manufacturers
• Approval Status
• Patent and Exclusivity Details
• Company Overview
• Phase III Drugs Information
• Phase III Drugs Description
• The United States Drug Master Filings (US DMF)
• Discontinued Drugs Information

Pharyngitis Therapeutic Market, US, Marketed Drugs by Application Type, 2014
Pharyngitis Therapeutic Market, US, Marketed Drugs by Marketing Status, 2014
Pharyngitis Therapeutic Market, US, (Year), 2014
Pharyngitis Marketed Drugs, API Manufacturers by US DMF Status, 2014
Pharyngitis Marketed Drugs, US DMF Status Drug Specific (Number), 2014
Pharyngitis Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2014
Pharyngitis Therapeutic Market, Global Sales (in million USD), 2014
Pharyngitis Marketed Drugs, API Manufacturers, Global, 2014
Pharyngitis Phase III Pipeline Drugs, United States Drug Master File (DMF), 2014
Discontinued Drugs for Pharyngitis, 2014

Pharyngitis Therapeutic Market, US, Marketed Drugs by Application Type (%), 2014
Pharyngitis Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2014
Pharyngitis Therapeutic Market, US, (Year), 2014
Pharyngitis Marketed Drugs, API Manufacturers by US DMF Status (%), 2014
Pharyngitis Marketed Drugs, US DMF Status Drug Specific (Number), 2014
Pharyngitis Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2014
Pharyngitis Therapeutic Market, Global Sales (in million USD), 2014
Pharyngitis Marketed Drugs, Patent/Exclusivity Expiry (Year), 2014

*** 掲載企業 ***

Corden Pharma International GmbH
Eli Lilly and Company
AbbVie Inc.
Pfizer Inc.
UCB S.A.
Vansen Pharma
Shionogi Inc.
Lupin Pharmaceuticals, Inc.
Lilly USA, LLC
Pernix Therapeutics Holdings, Inc.
Bristol-Myers Squibb Company
Mayne Pharma Limited
Hospira, Inc.
Endo Pharmaceuticals Inc.
UCB, Inc.
Fisons Limited
Johnson & Johnson
GlaxoSmithKline Inc.
ANI Pharmaceuticals, Inc.
King Pharmaceuticals Ltd
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Wyeth (Inactive)
Mallinckrodt plc
Novartis AG
Schwarz Pharma AG
Alza Corporation
sanofi-aventis U.S. LLC.
Forest Laboratories, Inc.
Bayer HealthCare Pharmaceuticals Inc.
Warner Chilcott Plc
Banner Pharmacaps, Inc.
Teva Pharmaceuticals USA, Inc.
McNeil Consumer Healthcare
Hawthorn Pharmaceuticals, Inc.

*** レポートのキーワード ***

Pharyngitis、医薬品、治療薬、規模、販売量、医薬品有効成分(API)メーカー、第Ⅲ相試験、製薬

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 世界及び中国のイソプロピルエチルチオノカルバメート(IPETC)市場2018
    The 'Global and Chinese Isopropyl Ethyl thionocarbamate (IPETC) Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Isopropyl Ethyl thionocarbamate (IPETC) industry with a focus on the Chinese market. The report provides key statistics …
  • ドイツにおけるマイニング(採鉱)市場の財政・制度動向
    The mining industry in Germany is governed by the Federal Ministry of Economics and Technology (FMET) and Federal Institute for Geosciences and Natural Resources (BGR). The Federal Mining Act 1980 is the main regulating act for mining industry in the country.
  • 調味料、ドレッシング及びソース市場データ(~2017):アルジェリア
    Synopsis "Seasonings, Dressings & Sauces Market in Algeria: Databook to 2017" is the result of Canadean’s extensive market research covering the Seasonings, Dressings & Sauces market in Algeria. The report presents detailed historic and forecast data on the Seasonings, Dressings & Sauces consumption …
  • 4軸マシニングセンターの世界市場2016
    The Global 4-Axis Machining Centers Industry 2016 Market Research Report is a professional and in-depth study on the current state of the 4-Axis Machining Centers industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry …
  • アメリカの塗料・ワニス市場(~2019)
    The industry report Paint and Varnish Market in United States to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for paints and varnishes in United States. The research includes historic market data from 2008 to …
  • 冷凍肉(Frozen Meat)市場(~2017):フィンランド
    Synopsis The report presents detailed data on consumption trends in the Frozen Meat category in Finland, analyzing consumption volumes and values at segment level. It also provides indispensable data on distribution channels along with latest industry news and mergers and acquisitions (of Meat marke …
  • Cutaneous T-Cell Lymphoma:パイプライン分析(ヘルスケア市場レポート)H1 2013
    Cutaneous T-Cell Lymphoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Cutaneous T-Cell Lymphoma, …
  • 医療料金アウトソーシングの世界市場2015-2019
    About Global Medical Billing Outsourcing Globally, healthcare spending is expected to increase, which will put additional pressure on healthcare delivery systems, governments, and insurers. The major reasons for increased spending in developed countries are an aging population and lower fertility ra …
  • 分流器の世界市場2016
    The Global Flow Dividers Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Flow Dividers industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The …
  • 反射鏡なしトータルステーション経緯儀の世界市場2016
    The Global Reflectorless Total Station Theodolites Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Reflectorless Total Station Theodolites industry. Firstly, the report provides a basic overview of the industry including definitions, classificati …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIIR2014142 )"Pharyngitis:治療薬市場動向2014(市場規模、グローバルAPIメーカー、第Ⅲ相試験)" (英文: Pharyngitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。